Optometrist · Flushing, NY
NPI
1568562775
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
14020 Sanford Ave, Suite 1c
Flushing, NY, 11355
Phone (718) 762-3838
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
748 services
Medicare patients, 2024
100
Average age 77
Drug cost, 2024
$2.1M
4,210 prescriptions
Company payments, 2025
$913
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy Y Chen was code 68761 (eye), 157 times for 53 patients. In total Amy Y Chen billed 748 services in 18 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 68761 Eye | Office | 157 | 53 | $92.92 | $15K |
| 92012 Ophthalmological E&M | Office | 131 | 68 | $71.25 | $9,334 |
| 92250 Angiography | Office | 123 | 94 | $28.81 | $3,543 |
| 92083 Vision, Hearing, and Speech Services | Office | 102 | 80 | $51.99 | $5,303 |
| 92133 Computerized Ophthalmic Imaging | Office | 63 | 54 | $27.75 | $1,748 |
| 92014 Ophthalmological E&M | Office | 56 | 55 | $103.33 | $5,787 |
| 76512 Ultrasound - Nonspecific | Office | 49 | 37 | $45.95 | $2,251 |
| 92004 Ophthalmological E&M | Office | 18 | 18 | $104.98 | $1,890 |
By year: 2022 $55K for 858 services; 2023 $47K for 750 services; 2024 $52K for 748 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy Y Chen prescribed most often to Medicare patients was Restasis (Cyclosporine), with 2,102 prescriptions and refills. In total Amy Y Chen wrote 4,210 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 2,102 | 2,527 | 482 | $1.6M |
| Loteprednol Etabonate Generic | 232 | 281 | 83 | $55K |
| Latanoprost Generic | 225 | 344 | 46 | $1,830 |
| Cyclosporine Generic | 211 | 281 | 62 | $68K |
| Erythromycin Erythromycin Base | 147 | 150 | 81 | $1,846 |
| Ciprofloxacin Hcl Generic | 129 | 134 | 75 | $1,676 |
| Alphagan P Brimonidine Tartrate | 126 | 214 | 30 | $47K |
| Bepotastine Besilate Generic | 125 | 155 | 42 | $19K |
| Azelastine Hcl Generic | 103 | 105 | 34 | $2,025 |
| Brimonidine Tartrate Generic | 98 | 154 | 25 | $14K |
| Miebo Perfluorohexyloctane/Pf | 74 | 79 | 45 | $57K |
| Lotemax Sm Loteprednol Etabonate | 63 | 63 | 30 | $16K |
| Tobradex Tobramycin/Dexamethasone | 62 | 62 | 36 | $17K |
| Xiidra Lifitegrast | 62 | 72 | 20 | $49K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 53 | 57 | 35 | $2,811 |
Brand drugs: 3,332 claims; generic drugs: 878 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy Y Chen $913 ($913 in general payments such as food, travel and fees) from 8 companies. The largest payer was Bausch & Lomb Americas Inc. with $265.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.